Doctors Get New Clinical Guidelines for Managing Chronic Pain With Cannabis, Courtesy of Canadian Researchers
by Bethan Rose
1-833-663-7284 (Customer Support Available 24/7)
by Gary Miller
In response to a significant increase in research on Schedule I controlled substances, the U.S. Drug Enforcement Administration (DEA) has proposed dramatically raised levels of legal cannabis and psychedelic production in 2022 for use in studies.
After already increasing production quotas for 2021, the DEA is calling for a 60% increase in marijuana production. This will bring overall marijuana production from 2 million grams to 3.2 million grams, according to reporting by Marijuana Moment.
The agency is also working rapidly to approve applications for cultivating and manufacturing Schedule I substances in order to meet these new quotas. There is a particular emphasis on processing marijuana manufacturer applications, as the licensed production of research-grade cannabis is currently limited to the University of Mississippi.
“DEA supports regulated research with Schedule I controlled substances, as evidenced by increases proposed for 2022 as compared with aggregate production quotas for these substances in 2021,” the agency stated.
Alongside cannabis, the DEA is looking to produce more LSD, psilocybin, and MDMA. The agency has proposed a 6,300% boost in MDMA production and a 1,150% boost in LSD production. The director of the National Institute on Drug Abuse (NIDA), Nora Volkow, previously expressed that she felt encouraged by the DEA’s initiatives to increase substance production quotas.
According to research, “Migraine is highly prevalent, affecting 12% of the population, attacking up to 17% of women and 6% of men yearly. Among children, it tends to happen more in girls than boys.” A migraine can be very disabling and last from hours to two or three days. Migraines are considered to be the…
PTSD can have far-reaching effects on health, functionality as well as on quality of living, which is why having access to effective treatment is so important. If you are living with PTSD or are living with someone who has PTSD, you would have first-hand experience with how challenging it can be getting through life on…
Up until recently, lack of cannabis education meant that people were blissfully unaware of the fact that the plant is not limited to just one strain and, therefore, does not produce just one type of effect. Fortunately, agricultural experimentation has led to the market exploding in terms of strains that can satisfy everyone, from beginners…
Using cannabis to help combat anxiety is a tricky business. Studies have given us significant evidence that cannabis can be used to help cope with anxiety and because anxiety is so common, that’s an extremely welcome piece of information. In fact, 72% of daily cannabis users reported consumption to relax or relieve tension and 58%…
A cannabis compound that has been described as “cutting-edge” and “so elusive, laboratories often misidentify the compound as CBC (cannabichromene) or CBL (cannabicyclol)” is finally becoming better understood. Delta-10-tetrahydrocannabinol (delta-10 THC) is a need-to-know cannabinoid, and here’s why. What Is Delta-10 THC? Does Delta-10 Get You High? Is Delta-10 Safe? How Is Delta-10 Created? Is…
The anti-nausea and vomiting effects of cannabis have been known for several centuries. The evidence eventually became so compelling in clinical trials…
Experts are taking a bird’s eye view of an exciting and rapidly evolving area in cannabis research known as the endocannabinoidome (eCBome)….
Spliffs and joints, while similar, are different cannabis products rolled up in paper. If you are a seasoned cannabis smoker, you’re probably…
